Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Paul is Director of Medicinal Chemistry for Cancer Therapeutics CRC and is responsible for leading a team of post-doctoral medicinal chemists at Monash Institute for Pharmaceutical Sciences. Prior to joining CTx in 2012, Paul worked at the Pfizer laboratories in Sandwich, UK where he led medicinal teams which contributed to the delivery of numerous clinical candidates, of which three have so far reached Phase II clinical trials.

Prior to joining Pfizer in 2000, Paul completed his undergraduate and postgraduate studies at the University of Oxford, UK.

Related Links:

  • Cancer Therapeutics CRC

Research interests

Small molecule drug discovery for oncology

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Organic Chemistry, DPhil, University of Oxford

1 Oct 199620 Dec 1999

Award Date: 31 Jan 2000

Chemistry, BA, University of Oxford

1 Oct 199231 Jul 1996

Award Date: 31 Aug 1996

External positions

Director, Medicinal Chemistry, CANthera

1 Jan 2021 → …

Director, Medicinal Chemistry, Cancer Therapeutics (CRC)

24 Jan 201231 Dec 2020


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or